1
|
Faggyas RJ, Sloan NL, Buijs N, Sutherland A. Synthesis of Structurally Diverse Benzotriazoles via Rapid Diazotization and Intramolecular Cyclization of 1,2-Aryldiamines. European J Org Chem 2019. [DOI: 10.1002/ejoc.201900463] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Réka J. Faggyas
- WestCHEM, School of Chemistry, The Joseph Black Building; University of Glasgow; Glasgow G12 8QQ United Kingdom
| | - Nikki L. Sloan
- WestCHEM, School of Chemistry, The Joseph Black Building; University of Glasgow; Glasgow G12 8QQ United Kingdom
| | - Ned Buijs
- WestCHEM, School of Chemistry, The Joseph Black Building; University of Glasgow; Glasgow G12 8QQ United Kingdom
| | - Andrew Sutherland
- WestCHEM, School of Chemistry, The Joseph Black Building; University of Glasgow; Glasgow G12 8QQ United Kingdom
| |
Collapse
|
2
|
Martínez AG, Vilar ET, Jiménez FM, Martínez-Ruiz P, Vilaboa RB. Electron ionisation mass spectral studies of bridgehead-fused Delta2-norbornanethiazolines. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2009; 23:856-862. [PMID: 19224537 DOI: 10.1002/rcm.3950] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
The electron ionisation (EI) mass spectra of a series of bridgehead-fused Delta2-norbornanethiazolines, a new class of bridgehead-norbornane derivatives, have been studied and their cleavage mechanisms rationalised on the basis of the substituent shifts as well as on the identification of relevant peaks through accurate mass measurements and collision-induced dissociation tandem mass spectrometric experiments. The fragmentation patterns of isomeric pairs of 6,6- and 10,10-dimethylnorbornanethiazolines are almost identical, probably due to an initial isomerisation of molecular ion previous to the fragmentation. In general, the dominant peaks in the spectra of all the studied compounds originate from initial alpha-cleavages of C(5)-C(6) or C(1)-C(10) bonds, followed by concomitant homolytic cleavage of C(1)-C(9) and C(7)-C(10) bonds. The driving force for this fragmentation pathway, directed by the gem-dimethyl group, is the formation of a highly stabilised thiazolilmethyl cation which constitutes the base peak in all the spectra and allows the identification of these interesting ligands.
Collapse
Affiliation(s)
- Antonio García Martínez
- Departamento de Química Orgánica I, Facultad de Ciencias Químicas, Universidad Complutense de Madrid (UCM), Ciudad Universitaria s/n, E-28040 Madrid, Spain.
| | | | | | | | | |
Collapse
|
3
|
Gaumont AC, Gulea M, Levillain J. Overview of the Chemistry of 2-Thiazolines. Chem Rev 2009; 109:1371-401. [DOI: 10.1021/cr800189z] [Citation(s) in RCA: 134] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Annie-Claude Gaumont
- Laboratoire de Chimie Moléculaire et Thioorganique, UMR CNRS 6507, INC3M, FR 3038, ENSICAEN & Université de Caen, 14050 Caen, France
| | - Mihaela Gulea
- Laboratoire de Chimie Moléculaire et Thioorganique, UMR CNRS 6507, INC3M, FR 3038, ENSICAEN & Université de Caen, 14050 Caen, France
| | - Jocelyne Levillain
- Laboratoire de Chimie Moléculaire et Thioorganique, UMR CNRS 6507, INC3M, FR 3038, ENSICAEN & Université de Caen, 14050 Caen, France
| |
Collapse
|
10
|
Pfund E, Lequeux T, Masson S, Vazeux M. Synthesis of thiazolines linked to a difluoromethylphosphonate diester via dithioester chemistry. Org Lett 2002; 4:843-6. [PMID: 11869142 DOI: 10.1021/ol025544f] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
[reaction: see text] A two-step, high-yielding synthesis of delta(2)-thiazolines containing a difluoromethylphosphonate diester moiety has been devised using a building block approach. Racemic or chiral beta-amino alcohols and diols were coupled with methyl difluoro(diethoxyphosphono)dithioacetate to give predominantly the corresponding beta-hydroxythioamides, which were then cyclized to provide a series of novel substituted delta(2)-thiazolines.
Collapse
Affiliation(s)
- Emmanuel Pfund
- Laboratoire de Chimie Moléculaire et Thio-organique UMR CNRS 6507 ISMRA, UFR Sciences, Université de Caen, 6 Bd Maréchal Juin, 14050 Caen Cedex, France
| | | | | | | |
Collapse
|
16
|
Wipf P, Reeves JT, Balachandran R, Giuliano KA, Hamel E, Day BW. Synthesis and Biological Evaluation of a Focused Mixture Library of Analogues of the Antimitotic Marine Natural Product Curacin A. J Am Chem Soc 2000. [DOI: 10.1021/ja002213u] [Citation(s) in RCA: 79] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Peter Wipf
- Contribution from the Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, Department of Environmental and Occupational Health, and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15238, Cellomics, Inc., Pittsburgh, Pennsylvania 15238, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick
| | - Jonathan T. Reeves
- Contribution from the Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, Department of Environmental and Occupational Health, and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15238, Cellomics, Inc., Pittsburgh, Pennsylvania 15238, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick
| | - Raghavan Balachandran
- Contribution from the Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, Department of Environmental and Occupational Health, and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15238, Cellomics, Inc., Pittsburgh, Pennsylvania 15238, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick
| | - Kenneth A. Giuliano
- Contribution from the Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, Department of Environmental and Occupational Health, and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15238, Cellomics, Inc., Pittsburgh, Pennsylvania 15238, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick
| | - Ernest Hamel
- Contribution from the Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, Department of Environmental and Occupational Health, and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15238, Cellomics, Inc., Pittsburgh, Pennsylvania 15238, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick
| | - Billy W. Day
- Contribution from the Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, Department of Environmental and Occupational Health, and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15238, Cellomics, Inc., Pittsburgh, Pennsylvania 15238, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick
| |
Collapse
|